Fig. 5
From: Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1
Cell viability of GBC-X1 cells after 72 h of exposure to anticancer drugs. GBC-X1 is resistant to oxaliplatin (A) and sensitive to fluorouracil (B), gemcitabine (C), and paclitaxel (D).
